Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Muhammad Furqan; Yamei Chen; Akintunde Akinleye; Judy Sarungbam; Alan Gass; Karen Seiter; Delong Liu

doi:10.1007/s11684-014-0319-1

Front. Med. ›› 2014, Vol. 8 ›› Issue (2) : 254 -258. DOI: 10.1007/s11684-014-0319-1

CASE REPORT

Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Author information +

History +

PDF (922KB)

Abstract

Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term “mantle cell lymphoma” in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.

Keywords

mantle cell lymphoma / bendamustine / cardiogenic shock

Cite this article

Download citation ▾

Muhammad Furqan,Yamei Chen,Akintunde Akinleye,Judy Sarungbam,Alan Gass,Karen Seiter,Delong Liu. Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock. Front. Med., 2014, 8(2): 254-258 DOI:10.1007/s11684-014-0319-1